- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mi | FDA cracks down on illegal ketamine sellers amid nearing 'psychedelic revolution' | ||
| Mi | Kalohexis confidentially files IPO to back obesity and cachexia portfolio | ||
| Mi | Novo Nordisk signs pact with Vivani for long-lasting semaglutide implant | ||
| Mi | FDA grants rare paediatric designation to Vanda's CMT2S therapy | ||
| Mi | Biocytogen and Whitehawk partner to develop ADCs | ||
| Di | Merck KGaA-backed Cyllene Therapeutics secures €33m for gene therapy pipeline | ||
| Di | Vertex signs agreement to acquire Crinetics for $10bn | ||
| Di | EC approves AbbVie's Tepkinly combination for follicular lymphoma | ||
| Mo | UK biotechs struggling to access finance as scale-up concerns grow | ||
| Mo | Novartis to acquire Myricx Bio in up to $1.5bn deal | ||
| Mo | Roche pens $490m Astex breast cancer license deal | ||
| Mo | Besins Healthcare boosts drug delivery portfolio with UniD deal | ||
| Fr | WHO intensifies Ebola-curbing efforts through drug trial and diagnostic rollout | ||
| Fr | US-UK pharma trade deal paints a costly economic picture for NHS | ||
| Fr | SK bioscience to lead Gates Foundation-funded ROTOR project | ||
| Fr | European Commission approves Novartis' Itvisma to treat SMA | ||
| 02.07. | Ipsen bolsters rare disease pipeline in €700m Memo takeover | ||
| 02.07. | FDA widens Vertex's Casgevy use for paediatric patients | ||
| 02.07. | Insilico Medicine, Takeda partner on AI-driven drug discovery | ||
| 02.07. | Inocras, AimedBio team up for cancer treatments | ||
| 01.07. | QuantumCell commits $2.2bn on AlzeCure's Alzheimer's platform | ||
| 01.07. | Sanofi aims for Nexviazyme approval in younger Pompe disease patients | ||
| 01.07. | Anthropic debuts AI-driven pharma R&D tool, Claude Science | ||
| 01.07. | Medical journal retracts Tavneos pivotal paper amid wider regulatory clampdown | ||
| 01.07. | US FDA rejects approval of Unicycive's kidney disease therapy |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.